SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-012449
Filing Date
2023-04-17
Accepted
2023-04-17 08:00:52
Documents
82
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1899335
2 ex4-1.htm EX-4.1 18284
3 ex21-1.htm EX-21.1 5825
4 ex23-1.htm EX-23.1 3755
5 ex31-1.htm EX-31.1 18394
6 ex31-2.htm EX-31.2 18470
7 ex32-1.htm EX-32.1 9204
8 form10-k_001.jpg GRAPHIC 7839
9 form10-k_002.jpg GRAPHIC 6705
  Complete submission text file 0001493152-23-012449.txt   9143002

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ghsi-20221231.xsd EX-101.SCH 59454
11 XBRL CALCULATION FILE ghsi-20221231_cal.xml EX-101.CAL 69581
12 XBRL DEFINITION FILE ghsi-20221231_def.xml EX-101.DEF 314132
13 XBRL LABEL FILE ghsi-20221231_lab.xml EX-101.LAB 530617
14 XBRL PRESENTATION FILE ghsi-20221231_pre.xml EX-101.PRE 426376
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1475520
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38861 | Film No.: 23822845
SIC: 2834 Pharmaceutical Preparations